---
title: Evaluation of long-term safety in parkinsonian patients with intracerebroventricular administration of A-dopamine (anaerobic dopamine) - (DIVE-Follow up)
euct_id: 2025-522261-30-00
status: Not yet recruiting
sponsor: Centre Hospitalier Universitaire De Lille
canonical_url: "https://parkinsonspathways.com/trials/eu/2025-522261-30-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2025-522261-30-00"
ctis_last_updated: "2026-01-06T02:32:20.091008978"
source: EU Clinical Trials Information System (CTIS)
---
# Evaluation of long-term safety in parkinsonian patients with intracerebroventricular administration of A-dopamine (anaerobic dopamine) - (DIVE-Follow up)

**EU CT Number:** [2025-522261-30-00](https://euclinicaltrials.eu/ctis-public/view/2025-522261-30-00)

## Key Facts

- **Status:** Not yet recruiting
- **Sponsor:** Centre Hospitalier Universitaire De Lille
- **Start Date:** 2025-10-01
- **Completion Date:** 2026-09-30
- **Conditions:** Parkinson disease, Parkinson's disease

## Member States

Trial is authorized in 1 member state: France.

## Sites (1)

- Centre Hospitalier Universitaire De Lille, Lille Cedex, France

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson disease; Parkinson's disease
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2025-522261-30-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2025-522261-30-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2025-522261-30-00*